来自A2A腺素受体对抗剂癌症治疗临床试验的见解
Pran Kishore Deb1, Prasenjit Maity1, Biprajit Sarkar1
1Department of Pharmaceutical Sciences & Technology, Birla Institute of Technology, Mesra, 835215, Ranchi India.
ACS pharmacology & translational science
|June 19, 2025
概括
腺素 (ADO) 积累抑制了瘤中的免疫系统. 向A2A受体,特别是在组合疗法中,可以增强抗癌免疫力,克服免疫逃避.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 瘤微环境中的腺素 (ADO) 积累会产生一种免疫抑制状态.
- 这种免疫抑制是由腺A2A受体 (A2A R) 信号传递的媒介,促进癌症的进展.
- 在早期临床试验中,A2A R抗剂单一治疗显示出有限的抗癌效应.
研究的目的:
- 审查调节癌症中的腺/A2A受体信号传递的治疗潜力.
- 检查A2A R信号传递的机制和A2A R抗剂的临床进展.
- 讨论恢复抗瘤免疫力的组合策略.
主要方法:
- 审查关于腺信号传递和A2A R抗剂的现有文献.
- 对A2A R抗剂和组合疗法的临床前和临床数据的分析.
- 讨论双重A2A/A2B受体对抗剂及其作用.
主要成果:
- A2A R信号传递是癌症中一个关键的免疫抑制机制.
- 组合疗法,特别是免疫检查点抑制剂,显示出增强的抗癌潜力.
- 双重A2A/A2B受体对抗剂代表了一个新的治疗途径.
结论:
- 向腺/A2A受体可以增强抗瘤免疫反应.
- 合理的组合策略对于克服癌症免疫规避至关重要.
- 调节腺信号传递为癌症治疗提供了有希望的前景.
相关概念视频
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
998
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
998
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
1.1K
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
1.1K
Adrenergic Receptors: ɑ Subtype
2.1K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
2.1K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
908
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
908
Adrenergic Agonists: Therapeutic Uses
993
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
993
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


